Congenital Heart Disease clinical trials
69 active trials name this condition. Describe your situation to see which ones look like a fit.
By location
- HFNC vs NIPPV Following Extubation
- Effect of Sacubitril-Valsartan on Cardiac Structure and Function
- Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study
- Autus Valve Continued Access Study (CAS)
- Efficacy Of Sodium Glucose Transporter Inhibitor (SGLT2I) In Adult Patients With Congenital Heart Disease
- Fontan Fitness Trial
- Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System
- Autologous Induced Pluripotent Stem Cells of Cardiac Lineage for Congenital Heart Disease
- Hydrogen's Feasibility and Safety as a Therapy in ECPR
- Congenital Heart Disease Physical Activity Lifestyle Study V.2
- Remote Cardiac Rehab for Adolescents With Congenital Heart Disease
- NO During CPB in Neonates to Reduce Risk of AKI
- The Sequencing for Detection in Congenital Heart Disease (SD-CHD) Study
- A Study of Hemodynamic Cardiopulmonary Exercise for CHD
- Implementing Models for Mechanical Circulatory Support Presurgical Assessment in Congenital Heart Disease Treatment
- PRecision Integrated Saturation Monitor
- Psychological Trauma, Post-Traumatic Stress Disorder, and Resilience in Adults With Congenital Heart Disease
- PDA for Kidneys Study
- Clinical Readiness Skin Punch Biopsy Sample Collections
- Skin Pigment/Pulse Oximeter in Congenital Heart Disease (CHD)
- The Co-Op @ HeartWorks
- Extracellular Vesicle Micro RNA Profiling in Congenital Heart Disease: Fetal-Maternal Regulation in Neonatal Thrombosis
- A Study of Invasive Hemodynamic for MACHD Registry
- Application of a Clinical Decision Support System to Reduce Mechanical Ventilation Duration After Cardiac Surgery in Children
- IPSC Repository of Pediatric Cardiovascular Disease
- Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Severity Assessment
- Atrial Late Gadolinium Enhancement in Patients with Repaired Congenital Heart Disease
- Outcomes and Health Care Resource Utilization in Pediatric Congenital Heart Disease Patients Undergoing Non-Cardiac Procedures
- Evaluation of Pro-Inflammatory Leukocyte Activity in Patients Undergoing Cardiac Surgery
- ATrial Tachycardia PAcing Therapy in Congenital Heart
- Physical Activity and Cognitive Development in Children
- Genetics of Congenital Heart Disease
- Molecular and Cellular Characterization of Cardiac Tissue in Postnatal Development
- Remote Monitoring in Pregnant Women With Congenital Heart Disease Using Wrist Wearables
- Effect of Fetal Aortic Valvuloplasty on Outcomes
- Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure
- Cardiology Biobank Registry
- Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders
- Triple EIT (Electrical Impedance Tomography)
- Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry
- The Heart Outcomes in Pregnancy Expectations for Mom and Baby Study
- Development of CIRC Technologies
- Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of Fallot and Other Congenital Heart Diseases
- Technical Development of Cardiovascular Magnetic Resonance Imaging
- Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise
- Implementation of an Accessible Healthcare Model (ACHD STRONG): Comparing Nurse and Physician Lead Healthcare Transition Education in a RE-AIM Framework
- Improving Congenital Heart Disease Care
- Aim 3: Pilot Study of a Serious Game to Promote Transition Readiness Skills
- Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery
- A Pragmatic Clinical Trial of the WE BEAT Well-Being Education Program in Adolescent Congenital Heart Disease: WE BEAT CHD Study
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Congenital Heart Disease” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.